BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 5866433)

  • 21. [Our experience with a new synthetic spasmolytic drug in the obsterico-gynecologic field].
    Abelli G
    Minerva Ginecol; 1968 Jun; 20(12):1051-7. PubMed ID: 5750898
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of intrapelvic novocaine blocks in the overall treatment of threatened and beginning late abortions and premature labor].
    Il'ina RI
    Vopr Okhr Materin Det; 1974 May; 19(5):73-6. PubMed ID: 4464646
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of threatened abortion and premature labor with Duvadilan].
    Neumann H; Manteuffel U
    Zentralbl Gynakol; 1970 Aug; 92(34):1100-8. PubMed ID: 4102713
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical use of a beta-mimetic drug in the control of uterine dynamics].
    Casati G; Scaglione V; Vandelli I
    Ann Ostet Ginecol Med Perinat; 1973; 94(9-10):587-94. PubMed ID: 4806144
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention of respiratory distress in premature infants through pernatal treatment with betamethasone].
    Di Meglio L; Furbatto G; Gallo G; Vercellotti E
    Minerva Ginecol; 1979; 31(7-8):557-62. PubMed ID: 481813
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical use of Intaserin for the therapy of premature labor and abortion].
    Izuchi S; Kuga S; Yamashita H
    Sanfujinka No Jissai; 1969 Feb; 18(2):181-4. PubMed ID: 5818866
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of the administration of tocopherol on threatened abortion, premature labor and toxemia of late pregnancy.
    Akasu F; Tateno M
    J Jpn Obstet Gynecol Soc; 1966 Apr; 13(2):91-7. PubMed ID: 5973837
    [No Abstract]   [Full Text] [Related]  

  • 28. [Value of Avafortan dragées and suppositories in current gynecologic and medical practice].
    Szwarcberg R; Keller B
    Therapeutique; 1971 Mar; 47(3):265-7. PubMed ID: 5557328
    [No Abstract]   [Full Text] [Related]  

  • 29. The effectivity of Bricanyl (terbutaline) treatment in the prevention and management of threatening abortion and premature delivery, respectively, within the frames of outpatients' services.
    Tóth B; Avar Z; Bálint T
    Ther Hung; 1982; 30(2):88-92. PubMed ID: 6926911
    [No Abstract]   [Full Text] [Related]  

  • 30. [Is surgical-tocolytic prevention and therapy of cervical insufficiency justified without prenatal diagnostic care?].
    Bergner R; Fröhlich HH
    Zentralbl Gynakol; 1977; 99(26):1624-8. PubMed ID: 607700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of early threatened abortion (6th-16th week of pregnancy) using a new tocolytic agent (Th 1165a)].
    Bärmig H; Krzoska C
    Zentralbl Gynakol; 1974 Jan; 96(2):55-8. PubMed ID: 4606038
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effects of Diazepam in threatened interruption of pregnancy].
    Muller P; Dellenbach P; Szwarcberg R
    Bull Fed Soc Gynecol Obstet Lang Fr; 1965; 17(3):261-4. PubMed ID: 5842005
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vitamin K in obstetrics--effects of vitamin K1 on threatened abortion and premature labor].
    Hata Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1967 Nov; 19(11):1398-401. PubMed ID: 5627227
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of tocolysis as a routine method of preventing spontaneous abortions and premature labor].
    Veselinov Kh
    Akush Ginekol (Sofiia); 1983; 22(2):93-7. PubMed ID: 6638390
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical contribution on the use of delayed-action isoxsuprine in threatened abortion].
    Sola O; Colonna-Romano L
    Arch Ostet Ginecol; 1974; 79(5-6):326-35. PubMed ID: 4471560
    [No Abstract]   [Full Text] [Related]  

  • 36. [Course and outcome of labor after threatened abortion].
    Wallner H; Weidenbach A
    Geburtshilfe Frauenheilkd; 1970 Jun; 30(6):504-13. PubMed ID: 5475932
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of isoxsuprine hydrochloride in threatened abortion].
    Cazzola D
    Quad Clin Ostet Ginecol; 1967 Jun; 22(6):382-96. PubMed ID: 5628977
    [No Abstract]   [Full Text] [Related]  

  • 38. [Value of Salbutamol in obstetrics].
    Dellenbach P; Vors J
    Therapeutique; 1972 Dec; 48(10):671-5. PubMed ID: 4145202
    [No Abstract]   [Full Text] [Related]  

  • 39. [Spasmolytic therapy with Sistalgin in obstetrics and gynecology].
    Lucchese A
    Minerva Ginecol; 1975 Jul; 27(7):559-69. PubMed ID: 1239699
    [No Abstract]   [Full Text] [Related]  

  • 40. [Management of threatened abortion and premature delivery with Duvadilan and Dilatol].
    Hengst P; Neumann H
    Z Arztl Fortbild (Jena); 1971 Aug; 65(16):850-4. PubMed ID: 4946946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.